Elevance Health
ELV · New York Stock Exchange · Health Care
☆ Follow
Shareholder advocacy aimed at Elevance Health
1 recorded campaign from 1 organization.
Trillium Asset Management at Elevance Health, Inc.
The proposal asked Elevance's board to commission an independent study on adopting a policy against corporate contributions to partisan 527 political organizations, after the company gave more than $9.7 million to the Republican Governors Association and $1.3 million to the Republican Attorneys General Association since 2010.
What shareholders voted on
From Elevance Health’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.
2026
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal requesting a study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups | Shareholder proposal | 8.7% | Failed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 96% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 | Auditor | 90.1% | Passed | |
| Election of Gail K. Boudreaux | Director | 99% | Passed | |
| Election of Deanna D. Strable | Director | 97.6% | Passed | |
| Election of Robert L. Dixon, Jr. | Director | 96.9% | Passed |
2025
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal requesting a report on the effectiveness of Diversity, Equity, and Inclusion efforts | Shareholder proposal | 14% | Failed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 91.8% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2025 | Auditor | 88.4% | Passed | |
| Election of Susan D. DeVore | Director | 98% | Passed | |
| Election of Ryan M. Schneider | Director | 97.4% | Passed | |
| Election of Bahija Jallal | Director | 95.4% | Passed |
2024
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal requesting annual political activity reporting from third parties prior to the Company donating to the organization | Shareholder proposal | Nathan Cummings Foundation | 5.1% | Failed |
| Advisory vote on the Company’s executive compensation | Say on pay | 91.9% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2024 | Auditor | 89.2% | Passed | |
| Election of Lewis Hay, III | Director | 97.8% | Passed | |
| Election of Antonio F. Neri | Director | 96.7% | Passed | |
| Election of Ramiro G. Peru | Director | 93.6% | Passed |
2023
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders | Shareholder proposal | 46% | Failed | |
| The shareholder proposal requesting annual reporting from third parties seeking financial support from the Company | Shareholder proposal | 8.1% | Failed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 94.2% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2023 | Auditor | 92.4% | Passed | |
| Election of Gail K. Boudreaux | Director | 99.8% | Passed | |
| Election of R. Kerry Clark | Director | 99.4% | Passed | |
| Election of Deanna D. Strable | Director | 98.7% | Passed | |
| Election of Robert L. Dixon, Jr. | Director | 96.3% | Passed |
2022
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal to require the Company to engage a third party to conduct a racial impact audit and publicly disclose the audit results | Shareholder proposal | 41.2% | Failed | |
| The shareholder proposal to prohibit the use of corporate or PAC funds for direct or indirect contributions to candidates | Shareholder proposal | John Harrington | 4% | Failed |
| Advisory vote on the Company’s executive compensation | Say on pay | 92.5% | Passed | |
| The amendment to the Company’s Amended and Restated Articles of Incorporation to change the Company’s name to Elevance Health, Inc | Company proposal | 99.3% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022 | Auditor | 92.4% | Passed | |
| Election of Susan D. DeVore | Director | 99.8% | Passed | |
| Election of Ryan M. Schneider | Director | 98.9% | Passed | |
| Election of Elizabeth E. Tallett | Director | 96.9% | Passed | |
| Election of Bahija Jallal | Director | 96.7% | Passed |
2021
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Advisory vote on the Company’s executive compensation | Say on pay | 93.5% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2021 | Auditor | 93.3% | Passed | |
| Election of Lewis Hay, III | Director | 99.5% | Passed | |
| Election of Antonio F. Neri | Director | 97.8% | Passed | |
| Election of Ramiro G. Peru | Director | 96.8% | Passed |
2020
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal to allow shareholders owning 10% or more of the Company’s common stock to call a special meeting of shareholders | Shareholder proposal | 49.4% | Failed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 94.2% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2020 | Auditor | 94.8% | Passed | |
| Election of Gail K. Boudreaux | Director | 99.7% | Passed | |
| Election of R. Kerry Clark | Director | 99.6% | Passed | |
| Election of Robert L. Dixon, Jr. | Director | 98.7% | Passed |
2019
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal to elect each director annually at such time when it would not interfere with the Company’s existing contractual obligations | Shareholder proposal | 74.9% | Passed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 93.6% | Passed | |
| The amendments to the Articles of Incorporation to eliminate the classified board structure when permitted under the Company’s contractual obligations with the Blue Cross and Blue Shield Association | Company proposal | 99.9% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2019 | Auditor | 95.4% | Passed | |
| Election of Bahija Jallal | Director | 99.7% | Passed | |
| Election of Elizabeth E. Tallett | Director | 96.8% | Passed |
2018
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| The shareholder proposal requesting amendments to the Articles of Incorporation to allow shareholders owning 10% or more of the Company’s common stock to call special meetings of shareholders | Shareholder proposal | 45.1% | Failed | |
| Advisory vote on the Company’s executive compensation | Say on pay | 94.1% | Passed | |
| The amendments to the Articles of Incorporation to allow shareholders owning 20% or more of the Company’s common stock to call special meetings of shareholders | Company proposal | 97.8% | Passed | |
| Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2018 | Auditor | 96.9% | Passed | |
| Election of Antonio F. Neri | Director | 99.7% | Passed | |
| Election of Lewis Hay, III | Director | 99% | Passed | |
| Election of Ramiro G. Peru | Director | 96.2% | Passed | |
| Election of Julie A. Hill | Director | 96.2% | Passed |
Proxy statements and vote results
Straight from Elevance Health’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.
| Year | Filing | Filed |
|---|---|---|
| 2026 | Vote results | 2026-05-13 |
| 2026 | Proxy statement | 2026-03-27 |
| 2025 | Vote results | 2025-05-14 |
| 2025 | Proxy statement | 2025-03-28 |
| 2024 | Vote results | 2024-05-15 |
| 2024 | Proxy statement | 2024-03-29 |
| 2023 | Vote results | 2023-05-11 |
| 2023 | Proxy statement | 2023-03-31 |
| 2022 | Vote results | 2022-05-19 |
| 2022 | Proxy statement | 2022-04-01 |
| 2021 | Vote results | 2021-05-27 |
| 2021 | Proxy statement | 2021-04-09 |
| 2020 | Vote results | 2020-05-21 |
| 2020 | Proxy statement | 2020-03-27 |
| 2019 | Vote results | 2019-05-15 |
| 2019 | Proxy statement | 2019-03-29 |
| 2018 | Vote results | 2018-05-16 |
| 2018 | Proxy statement | 2018-04-02 |
Do you represent Elevance Health? Claim this profile to respond to the campaigns listed here.